No price history available.

Based on consensus from external analysts. Not Kvantra's opinion.

Tilray Brands, Inc. operates as a global enterprise deeply involved in the entire lifecycle of cannabis products, from initial research and cultivation to manufacturing, marketing, and distribution. Its reach extends across a multitude of international markets, including Canada, the United States, Europe, Australia, New Zealand, and Latin America. The company's diverse operations are segmented into four key areas: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. Within its portfolio, Tilray provides a broad spectrum of medical and adult-use cannabis offerings, such as GMP-certified flowers, oils, vapes, edibles, and topicals. Beyond cannabis, the company also procures and resells various pharmaceutical and wellness products. Furthermore, Tilray is active in the production, promotion, and distribution of alcoholic beverages, alongside hemp-based food items and other wellness-focused goods. These numerous products are marketed under a wide array of brands, including Tilray, Aphria, Broken Coast, SweetWater, Breckenridge Distillery, and others. The company’s sales channels are extensive, serving retailers, wholesalers, individual patients, physicians, hospitals, pharmacies, researchers, government entities, and direct-to-consumer markets. Previously named Tilray, Inc., the corporation's main headquarters are situated in Leamington, Canada.

• Evolus, Inc.
• Synmosa Biopharma Corporation
• Shaanxi Kanghui Pharmaceutical Co., Ltd.
• Bliss GVS Pharma Limited
• RPG Life Sciences Limited
• Wuhan Hiteck Biological Pharma Co.,Ltd
• Tibet AIM Pharm. Inc.
• ScinoPharm Taiwan, Ltd.